CHEK1 and colorectal carcinoma: Also, RSR abrogation variably affects CSC survival [27], as we previously showed in a panel of CRC patient-derived tumorspheres enriched for CSCs (CRC-SCs) treated with ATR or CHK1 inhibitors [21].